Exclusive

Publication

Byline

Mankind's profit, revenue miss estimates in Q3, revenue rises 11.5%

New Delhi, Feb. 3 -- Mankind Pharma's net profit climbed 9.5% in the third quarter, missing estimates, as revenue increased, driven by domestic growth and consolidation of Bharat Serums and Vaccines L... Read More


Sun Pharma beats street estimates in Q3 with net profit up 16%

New Delhi, Jan. 31 -- The Mumbai-based drugmaker said its total sales rose 15.1% year-on-year to Rs.15,469 crore. Total revenue from operations rose 13.4% YoY to Rs.15,520.5 crore, the company said in... Read More


Sun Pharma Q3FY26 Preview: Innovative portfolio, India market to drive growth

New Delhi, Jan. 30 -- Sun Pharma, India's largest drugmaker, is set to post its results for the third quarter of the fiscal year on Saturday. While brokerages anticipate steady domestic growth and mar... Read More


Piramal Pharma points to early recovery signs after seeing red in Q3

New Delhi, Jan. 29 -- Piramal Pharma Ltd is starting to see early signs of a recovery in its contract manufacturing business, with order inflows picking up on the back of improved biopharma funding an... Read More


India-EU FTA may lower costs of novel drugs for Indian patients, medical equipment

New Delhi, Jan. 27 -- India's landmark free trade deal with the European Union, finalised on Tuesday, includes significant tariff cuts on exports of pharmaceutical products as well as optical, medical... Read More


Mint Explainer | US exits WHO: What it means for global health and America

New Delhi, Jan. 25 -- The US has formally withdrawn from the World Health Organization (WHO), a year after President Donald Trump signed an executive order to begin the process. The move deprives the... Read More


Sun Pharma gets DCGI nod to make generic version of Wegovy

New Delhi, Jan. 24 -- Sun Pharmaceutical Industries Ltd has received the Drugs Controller General of India's (DCGI) approval to make and market a generic version of semaglutide injection for weight ma... Read More


Syngene cuts guidance as key product loss weighs on growth

Mumbai, Jan. 23 -- Contract drug research and manufacturing firm Syngene International Ltd has lowered its full-year revenue guidance from mid-single digit growth to negative 2-3%, as destocking of a ... Read More


Sun Pharma gets nod to make generic Wegovy

Mumbai, Jan. 23 -- Sun Pharmaceutical Industries Ltd has received the Drugs Controller General of India's (DCGI) approval to make and market a generic version of semaglutide injection for weight manag... Read More


Zydus launches cancer biosimilar nivolumab at steep discount

MUMBAI, Jan. 22 -- Zydus Lifesciences has launched its biosimilar of anti-cancer drug nivolumab in India after receiving clearance from the Delhi High Court last week, pricing it at a fraction of the ... Read More